日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Macrophage Syk-PI3Kγ Inhibits Antitumor Immunity: SRX3207, a Novel Dual Syk-PI3K Inhibitory Chemotype Relieves Tumor Immunosuppression

巨噬细胞 Syk-PI3Kγ 抑制抗肿瘤免疫:新型双重 Syk-PI3K 抑制剂 SRX3207 可缓解肿瘤免疫抑制

Joshi, Shweta; Liu, Kevin X; Zulcic, Muamera; Singh, Alok R; Skola, Dylan; Glass, Christopher K; Sanders, P Dominick; Sharabi, Andrew B; Pham, Timothy V; Tamayo, Pablo; Shiang, Daniel; Dinh, Huy Q; Hedrick, Catherine C; Morales, Guillermo A; Garlich, Joseph R; Durden, Donald L

SF2523: Dual PI3K/BRD4 Inhibitor Blocks Tumor Immunosuppression and Promotes Adaptive Immune Responses in Cancer

SF2523:双重PI3K/BRD4抑制剂阻断肿瘤免疫抑制并促进癌症适应性免疫反应

Joshi, Shweta; Singh, Alok R; Liu, Kevin X; Pham, Timothy V; Zulcic, Muamera; Skola, Dylan; Chun, Hyun Bae; Glass, Christopher K; Morales, Guillermo A; Garlich, Joseph R; Durden, Donald L

A PKC-SHP1 signaling axis desensitizes Fcγ receptor signaling by reducing the tyrosine phosphorylation of CBL and regulates FcγR mediated phagocytosis

PKC-SHP1信号轴通过降低CBL的酪氨酸磷酸化水平来降低Fcγ受体信号的敏感性,并调节FcγR介导的吞噬作用。

Joshi, Shweta; Singh, Alok Ranjan; Zulcic, Muamera; Durden, Donald L

Rac2 controls tumor growth, metastasis and M1-M2 macrophage differentiation in vivo.

Rac2 在体内控制肿瘤生长、转移和 M1-M2 巨噬细胞分化

Joshi Shweta, Singh Alok R, Zulcic Muamera, Bao Lei, Messer Karen, Ideker Trey, Dutkowski Janusz, Durden Donald L